You searched for liver disease | Page 196 of 423

QIAGEN Receives FDA EUA for Rapid COVID Test

QIAGEN has received emergency use authorization (EUA) from the FDA for its QIAreach SARS CoV-2 Antigen Test.

There are an array of non-invasive serological tests that are highly accurate and can help cut the time to celiac disease diagnosis.

Lab stewardship programs can help with decision making and actionable insights for the right testing decisions and better quality outcomes.

LumiraDx has announced receiving FDA EUA for its SARS-CoV-2 Ab test, which is used to help identify an adaptive immune response to SARS-CoV-2.

Posted by Chris Wolski | Aug 4, 2021 | Covid 19 |

Scientists at the CDC recently marked the importance of fixed tissue analysis for retrospective diagnosis of COVID-19 infection.